{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:30:49Z","timestamp":1792683049442,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministero dell\u2019Universit\u00e0 e della Ricerca"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.bcp.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,5,15]],"date-time":"2016-05-15T01:02:39Z","timestamp":1463274159000},"page":"72-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Adenosine signalling mediates the anti-inflammatory effects of the COX-2 inhibitor nimesulide"],"prefix":"10.1016","volume":"112","author":[{"given":"Elisabetta","family":"Caiazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lapucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Paccosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Steckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lavecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Iuvone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Ialenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cicala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.05.006_b0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pharmthera.2005.04.013","article-title":"Adenosine 5\u2032-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation","volume":"112","author":"Bours","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2016.05.006_b0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002100000309","article-title":"Extracellular metabolism of ATP and other nucleotides","volume":"362","author":"Zimmermann","year":"2000","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2016.05.006_b0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2016.05.006_b0020","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.20040915","article-title":"Crucial role for ecto-5\u2032-nucleotidase (CD73) in vascular leakage during hypoxia","volume":"200","author":"Thompson","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2016.05.006_b0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1096\/fj.08-119701","article-title":"Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs","volume":"23","author":"Reutershan","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2016.05.006_b0030","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/sj.bjp.0707524","article-title":"Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction","volume":"1","author":"Palmer","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2016.05.006_b0035","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.38959","article-title":"Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis","volume":"67","author":"Botta Gordon-Smith","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcp.2016.05.006_b0040","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.4049\/jimmunol.1401416","article-title":"CD73 plays a protective role in collagen-induced arthritis","volume":"194","author":"Chrobak","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2016.05.006_b0045","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.22643","article-title":"The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5\u2032-nucleotidase: findings in a study of ecto-5\u2032-nucleotidase gene-deficient mice","volume":"56","author":"Montesinos","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2016.05.006_b0050","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/eji.200838437","article-title":"IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier","volume":"38","author":"Niemel\u00e4","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2016.05.006_b0055","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.96.11.6377","article-title":"Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB","volume":"96","author":"Cronstein","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.05.006_b0060","doi-asserted-by":"crossref","DOI":"10.1038\/srep15171","article-title":"Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway","volume":"5","author":"Veras","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2016.05.006_b0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10787-006-1505-9","article-title":"Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide","volume":"14","author":"Rainsford","year":"2006","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bcp.2016.05.006_b0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/092986708783497247","article-title":"Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug","volume":"15","author":"S\u00fcleyman","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2016.05.006_b0075","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1078-0432.CCR-0902-03","article-title":"Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma","volume":"10","author":"Shaik","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2016.05.006_b0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2008.10.028","article-title":"Nimesulide inhibits IFN-gamma-induced programmed death-1-ligand 1 surface expression in breast cancer cells by COX-2 and PGE2 independent mechanisms","volume":"276","author":"Liang","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2016.05.006_b0085","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.phrs.2008.03.003","article-title":"Nimesulide as a promising neuroprotectant in brain ischemia: new experimental evidences","volume":"57","author":"Candelario-Jalil","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2016.05.006_b0090","first-page":"255","article-title":"Effect of nimesulide on the indomethacin- and ibuprofen-induced ulcer in rat gastric tissue","volume":"54","author":"S\u00fcleyman","year":"2002","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.bcp.2016.05.006_b0095","first-page":"992","article-title":"Inhibition of neutrophil function in vitro by nimesulide. Preliminary evidence of an adenosine-mediated mechanism","volume":"43","author":"Capecchi","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bcp.2016.05.006_b0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejphar.2010.07.006","article-title":"Nimesulide improves the disease modifying anti-rheumatic profile of methotrexate in mice with collagen-induced arthritis","volume":"644","author":"Al-Abd","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2016.05.006_b0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bcp.2016.05.006_b0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bcp.2016.05.006_b0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cellbi.2006.03.001","article-title":"Up-regulation of ectonucleotidase activity after cortical stab injury in rats","volume":"30","author":"Nedeljkovic","year":"2006","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bcp.2016.05.006_b0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0003-2697(86)90640-8","article-title":"A direct colorimetric assay for Ca2+-stimulated ATPase activity","volume":"157","author":"Chan","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bcp.2016.05.006_b0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/bj2500369","article-title":"A novel assay for 5\u2032-nucleotidase using 1,N6-etheno-AMP as substrate, and comments on the properties of the reaction product, ethenoadenosine","volume":"250","author":"Jamal","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2016.05.006_b0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0006-2952(02)01548-4","article-title":"Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo","volume":"65","author":"Sitkovsky","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.05.006_b0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-2999(02)01305-5","article-title":"Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat","volume":"438","author":"Fozard","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2016.05.006_b0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.MIB.0000198535.13822.a9","article-title":"A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis","volume":"12","author":"Antonioli","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2016.05.006_b0145","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bmcl.2008.01.033","article-title":"Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease","volume":"18","author":"Mantell","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2016.05.006_b0150","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1097\/CCM.0b013e3181a55273","article-title":"Protective effects of adenosine A2A receptor agonist in ventilator-induced lung injury in rats","volume":"37","author":"Chen","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bcp.2016.05.006_b0155","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.transproceed.2010.02.084","article-title":"Activation of adenosine A2A receptor attenuates inflammatory response in a rat model of small-for-size liver transplantation","volume":"42","author":"Tang","year":"2010","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.bcp.2016.05.006_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054195","article-title":"A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats","volume":"8","author":"Vincenzi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2016.05.006_b0165","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.4049\/jimmunol.1003379","article-title":"Ecto-5\u2032-nucleotidase (CD73) decreases mortality and organ injury in sepsis","volume":"187","author":"Hask\u00f3","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2016.05.006_b0170","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bcp.2016.05.006_b0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI1554","article-title":"Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5\u2032-nucleotidase-mediated conversion of adenine nucleotides","volume":"101","author":"Morabito","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2016.05.006_b0180","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.4049\/jimmunol.172.3.1646","article-title":"IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5\u2032-nucleotidase) up-regulation","volume":"172","author":"Niemel\u00e4","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2016.05.006_b0185","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1002\/eji.200737793","article-title":"IFN-beta protects from vascular leakage via up-regulation of CD73","volume":"37","author":"Kiss","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2016.05.006_b0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","article-title":"Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade","volume":"1783","author":"Yegutkin","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2016.05.006_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031205","article-title":"Differential macrophage activation alters the expression profile of NTPDase and ecto-5\u2032-nucleotidase","volume":"7","author":"Zanin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2016.05.006_b0200","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuint.2012.06.017","article-title":"Regulation of ecto-5\u2032-nucleotidase (CD73) in cultured cortical astrocytes by different inflammatory factors","volume":"61","author":"Brisevac","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bcp.2016.05.006_b0205","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1038\/srep04486","article-title":"Ecto-5\u2032-nucleotidase (CD73) regulates host inflammatory responses and exacerbates murine salmonellosis","volume":"4","author":"Alam","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2016.05.006_b0210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/biom5020775","article-title":"Extracellular adenosine generation in the regulation of pro-inflammatory responses and pathogen colonization","volume":"5","author":"Alam","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2016.05.006_b0215","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0891-5849(94)90098-1","article-title":"Kinetic evaluation of lipophilic inhibitors of lipid peroxidation in DLPC liposomes","volume":"17","author":"Horan","year":"1994","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2016.05.006_b0220","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/jps.21218","article-title":"Effect of nonsteroidal anti-inflammatory drugs on the cellular membrane fluidity","volume":"97","author":"Sousa","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2016.05.006_b0225","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1189\/jlb.0709513","article-title":"A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux","volume":"87","author":"Bingham","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2016.05.006_b0230","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/ATVBAHA.111.226878","article-title":"Regulation of foam cells by adenosine","volume":"32","author":"Reiss","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521630079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521630079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:40:02Z","timestamp":1655944802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521630079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":46,"alternative-id":["S000629521630079X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.05.006","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenosine signalling mediates the anti-inflammatory effects of the COX-2 inhibitor nimesulide","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}